Scarica l'app Stockscreener
76.06
1.77%
1.32
Pre-mercato:
75.95
-0.11
-0.14%
Precedente Chiudi:
$74.74
Aprire:
$76.58
Volume 24 ore:
902.31K
Relative Volume:
1.17
Capitalizzazione di mercato:
$5.20B
Reddito:
-
Utile/perdita netta:
$-146.66M
Rapporto P/E:
-27.62
EPS:
-2.7541
Flusso di cassa netto:
$-133.21M
1 W Prestazione:
+2.03%
1M Prestazione:
+33.98%
6M Prestazione:
+81.01%
1 anno Prestazione:
+57.21%
Intervallo 1D:
$74.00
$76.75
Intervallo di 1 settimana:
$70.54
$77.08
Portata 52W:
$26.20
$77.08
Apogee Therapeutics Inc Stock (APGE) Company Profile
Nome
Apogee Therapeutics Inc
Settore
Industria
Telefono
650-394-5230
Indirizzo
221 CRESCENT ST., WALTHAM
Confronta APGE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
76.06 | 5.11B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-10 | Iniziato | Deutsche Bank | Buy |
| 2025-11-03 | Iniziato | Craig Hallum | Buy |
| 2025-10-21 | Iniziato | Mizuho | Outperform |
| 2025-09-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-07-07 | Reiterato | BTIG Research | Buy |
| 2025-03-13 | Iniziato | Citigroup | Buy |
| 2024-11-25 | Iniziato | Canaccord Genuity | Buy |
| 2024-05-10 | Iniziato | BofA Securities | Buy |
| 2023-12-20 | Iniziato | BTIG Research | Buy |
| 2023-08-08 | Iniziato | Guggenheim | Buy |
| 2023-08-08 | Iniziato | Jefferies | Buy |
| 2023-08-08 | Iniziato | Stifel | Buy |
| 2023-08-08 | Iniziato | TD Cowen | Outperform |
| 2023-08-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Apogee Therapeutics Inc Borsa (APGE) Ultime notizie
Deutsche Bank Initiates Apogee Therapeutics at Buy With $103 Price Target - marketscreener.com
Deutsche Bank Initiates Coverage of Apogee Therapeutics (APGE) with Buy Recommendation - Nasdaq
Apogee Therapeutics stock initiated with Buy rating at Deutsche Bank - Investing.com
Apogee Therapeutics stock initiated with Buy rating at Deutsche Bank By Investing.com - Investing.com India
Strong Pipeline and Analyst Confidence Push Apogee Therapeutics Inc. (APGE) Toward Growth - Yahoo Finance
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - The Manila Times
Certain Restricted Stock Units of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 8-DEC-2025. - marketscreener.com
Certain Stock Options of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 8-DEC-2025. - marketscreener.com
Apogee Therapeutics (NASDAQ:APGE) CEO Sells $3,000,400.00 in Stock - MarketBeat
Carl Dambkowski Sells 10,900 Shares of Apogee Therapeutics (NASDAQ:APGE) Stock - MarketBeat
Schroder Investment Management Group Boosts Stock Position in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics CMO sells $817k in stock By Investing.com - Investing.com South Africa
Insider Sell: Jane Henderson Sells 1,500 Shares of Apogee Therap - GuruFocus
Apogee Therapeutics CEO Henderson sells $3.0 million in stock By Investing.com - Investing.com Canada
Apogee Therapeutics CFO Henderson sells $112,500 in shares - Investing.com India
Apogee Therapeutics CMO sells $817k in stock - Investing.com
Apogee Therapeutics CFO Henderson sells $112,500 in shares By Investing.com - Investing.com UK
CFO Henderson Sells 1,500 ($112.5K) Of Apogee Therapeutics Inc [APGE] - TradingView
CEO Henderson Sells 40,000 ($3M) Of Apogee Therapeutics Inc [APGE] - TradingView
Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month HighHere's What Happened - MarketBeat
Prudential Financial Inc. Has $2.99 Million Stake in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics stock hits all-time high at 73.99 USD By Investing.com - Investing.com Australia
Apogee Therapeutics stock hits all-time high at 73.99 USD - Investing.com
Transcript : Apogee Therapeutics, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 09 - marketscreener.com
(APGE) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
How Apogee Therapeutics Inc. stock benefits from global expansionWeekly Profit Recap & Long-Term Growth Portfolio Plans - BỘ NỘI VỤ
Henderson, Apogee Therapeutics CFO, sells $105k in stock By Investing.com - Investing.com Canada
Apogee Therapeutics CFO Sells 1,500 Shares - TradingView
CFO Henderson Sells 1,500 ($105K) Of Apogee Therapeutics Inc [APGE] - TradingView
BofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic Dermatitis - MSN
Franklin Resources Inc. Lowers Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Geode Capital Management LLC Has $33.99 Million Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics (NASDAQ:APGE) Hits New 1-Year HighHere's Why - MarketBeat
Apogee Therapeutics Inc. $APGE Position Boosted by Jefferies Financial Group Inc. - MarketBeat
Is Apogee Therapeutics Inc a good long term investmentInsider Trading Compliance & High Yield Trading Alerts - earlytimes.in
Responsive Playbooks and the APGE Inflection - news.stocktradersdaily.com
Apogee Therapeutics (NASDAQ:APGE) Hits New 52-Week HighHere's What Happened - MarketBeat
Apogee Therapeutics stock hits 52-week high at $67.66 By Investing.com - Investing.com Nigeria
Apogee Therapeutics stock hits 52-week high at $67.66 - Investing.com
Is Apogee Therapeutics Inc. stock recession proofWeekly Stock Summary & High Conviction Buy Zone Picks - newser.com
How to track smart money flows in Apogee Therapeutics Inc.2025 Price Momentum & Daily Market Momentum Tracking - newser.com
How to use Fibonacci retracement on Apogee Therapeutics Inc.Market Activity Recap & Risk Controlled Stock Pick Alerts - newser.com
Apogee Therapeutics (NASDAQ:APGE) Rating Increased to Hold at Wall Street Zen - MarketBeat
How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsPortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Published on: 2025-11-15 19:11:00 - newser.com
Assessing Apogee Therapeutics (APGE) Valuation After Recent Surge in Investor Interest - Yahoo Finance
Why Apogee Therapeutics (APGE) Is Up 19.7% After Strong APG333 Trial Data and Cash Infusion - Yahoo Finance
Can volume confirm reversal in Apogee Therapeutics Inc.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Insider Sell Alert: Jane Henderson Sells 2,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Henderson Jane, CFO of Apogee Therapeutics, sells $130k in stock - Investing.com Canada
Apogee Therapeutics Inc Azioni (APGE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.45%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):